No Data
No Data
Express News | Northcog: Net profit increased 43.27% year-on-year in 2023, and plans to pay 10 to 2 yuan
Northgate (301333.SZ) announced first-quarter results, net profit of 23.489 million yuan, a decrease of 19.95%
Northgate (301333.SZ) released its report for the first quarter of 2024. The company's revenue was 177 million...
Norske (301333): Steady growth in clinical operations and SMO is optimistic about increasing market share of high-quality clinical CRO
The 2023 results are in line with our expectations, and the 2024Q1 results are lower than our expectations. The company announced its 2023 results: revenue of 720 million yuan, +13.15% year over year; net profit to mother of 160 million yuan, +43 year over year.
CRO concept stocks surged higher in the afternoon. Zhaoyan Pharmaceutical rose more than 8%, Tiger Pharmaceuticals rose more than 7%, and Norske, Haoyuan Pharmaceuticals, and Pharmaceutical Stone Technology rose more than 4%.
CRO concept stocks surged higher in the afternoon. Zhaoyan Pharmaceutical rose more than 8%, Tiger Pharmaceuticals rose more than 7%, and Norske, Haoyuan Pharmaceuticals, and Pharmaceutical Stone Technology rose more than 4%.
Norske (301333.SZ): Harmonious Growth Phase II and Harmonious Health plan to reduce their total holdings by no more than 3%
Gelonghui (301333.SZ) announced that shareholders holding 4,800,000 shares of the company (accounting for 5.0000% of the company's total share capital) Harmonious Growth Phase II (Yiwu) Investment Center (“Harmonious Growth Phase II”) and shareholders holding 2,155,200 shares of the company (accounting for 2.2450% of the company's total share capital ratio), Zhuhai Harmonious Health Investment Fund (limited partnership) (“Harmonious Health”) plan to reduce their share holdings through bulk transactions and centralized bidding transactions. Proposed reduction of shareholding by 2,880,000, proposed reduction of holdings
Express News | Norsk: Shareholders plan to reduce their holdings by no more than 3%
No Data